Ulta Beauty’s full-year sales forecast is slightly better, and the company says it’s ‘gaining traction’ in competitive backdrop

Date:

December 5, 2024

Shares of Ulta Beauty Inc. rallied after hours on Thursday after the cosmetics chain offered up a slightly more upbeat full-year sales forecast, saying efforts to counterbalance a slowdown in demand and steeper competition were showing signs of “gaining traction.”

Source link

Politifact Figure Accidently Exposes His Bias in Fact-Checking; the Media's Fix Is Completely Laid Bare

Breaking Down the Blackpink Members' Solo Careers by the Numbers

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Ulta Beauty’s full-year sales forecast is slightly better, and the company says it’s ‘gaining traction’ in competitive backdrop

Recent posts

Rich retirees win if Trump ends taxes on Social Security benefits — but there are plenty of losers

Treasury’s stable coupon, auction sizes at risk from U.S. election results

As third-quarter earnings approach, here are the stocks that analysts like — and dislike — the most

Hedge-fund manager who could be Trump Treasury secretary says tariffs can be negotiated lower

This chart shows gold vs. the stock market since Bernanke’s famous helicopter drop speech

How growing your dividends may work better than picking high-yielding stocks

ADP jobs report shows 143,000 gain. Cooling U.S. labor market leads to slower wage increases.

JPMorgan Chase is the best performer among U.S. banks. What that means for investors.

Harris and Trump command the market’s attention — but Jerome Powell may steal the spotlight

Hindenburg website hack adds to intrigue around short-selling firm’s closure

More retailers squeeze in earnings reports before Black Friday with holidays and tariffs in focus

Powell says Fed doesn’t need to hurry to cut interest rates

Why central banks’ hunger for gold shows ‘no sign of being quelled’ this year

Republicans clinch control of House, setting stage for quicker action on extending tax cuts

Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Related articles

Rich retirees win if Trump ends taxes on Social Security benefits — but there are plenty of losers

Lyft rolls out buyback, but outlook for key demand metric comes up short

As gold nears $3,000, here’s how its surge compares to bitcoin and the stock market

How growing your dividends may work better than picking high-yielding stocks

McDonald’s outlook improves, but these analysts have mixed views

Trump’s steel and aluminum tariffs aren’t rattling markets Monday. Blame investor fatigue.

Trump hits pause on blocking a trade loophole. Temu parent’s stock gains.

Inside the fight to stop Elon Musk and DOGE from accessing your personal financial information

Company

Follow us